Stimdia Medical Announces Close of Series B Equity Financing Round with Proceeds to be Used to Complete the Company’s Pivotal Study – link
July 2022 | News
Stimdia Medical receives FDA breakthrough device designation for the pdSTIM™ System designed to facilitate weaning patients from mechanical ventilation – link
March 2021 | News
Results of PEPNS study published in Critical Care Medicine, official journal of the Society of Critical Care Medicine (SCCM) – link
May 2020 | News
Results of PEPNS study presented during the European Society of Intensive Care Medicine’s (ESICM) 32nd Annual Congress held in Berlin, Germany – link
September 2019 | News
Stimdia Medical reports completion of enrollment and follow-up for PEPNS study
February 2019 | News
Stimdia Medical reports successful enrollment of first five patients in landmark PEPNS study
November 2018 | News
Stimdia Medical reports successful completion of 30 day follow-up on first two patients enrolled into landmark PEPNS study
October 2018 | News
Stimdia Medical receives country and ethics board approval in Ireland for PEPNS first in human study
August 2018 | News
Stimdia Medical receives country and ethics board approval in Czech Republic for PEPNS first in human study
July 2018 | News
Stimdia Medical completes GLP chronic study for PEPNS System
March 2018 | News
Stimdia Medical receives 2nd Tranche for Series A1 Financing
March 2018 | News
Stimdia Medical receives 1st Tranche for Series A1 Financing
December 2017 | News
Stimdia Medical completes GLP acute phase study for PEPNS System
December 2017 | News
Stimdia Medical granted landmark foundational patent associated with electrical stimulation for preservation and restoration of diaphragm function
June 2017 | News
Stimdia engages Minnetronix Medical to develop and manufacture beta console for pdSTIM System
May 2017 | News
Stimdia Medical engages Integer, one of the largest medical device OEMs in the world, to design and manufacture disposable lead for pdSTIM System
May 2017 | News
Stimdia Medical completes Series A Option 2x Financing
March 2017 | News
Stimdia completes market research and preclinical design evaluation studies
October 2016 | News
Stimdia completes proof of concept and technical feasibility studies for PEPNS System
May 2016 | News
Andarta Medical changes name to Stimdia Medical
March 2016 | News
Andarta Medical announces the hiring of John O’Mahony as Vice President of Research and Development
January 2016 | News
Andarta Medical closes Series A funding with world class investor syndicate Draper Triangle Ventures (Mr. Jay Katarinic), the University of Minnesota Discovery Capital Program (Mr. Russ Straate) and Industry Veteran Executive and Investor James Bullock
December 2015 | News
Patrick Wethington Announces the Founding and Incorporation of Andarta Medical out of University of Minnesota Office of Technology Commercialization
September 2015 | News
